LIPOSOMAL FORMULATION, PHARMACEUTICAL COMPOSITION, USE OF A LIPOSOMAL FORMULATION, METHOD FOR TREATING CANCER, AND PROCESS FOR PREPARING A LIPOSOMAL FORMULATION

摘要

The present invention relates to liposomal formulations comprising enzymes with asparaginase activity covalently linked to the ends of polyethylene glycol molecules exposed on the surface of liposomes. The liposomal formulations described herein can be used for treating cancer, particularly leukemias.